These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 917087)

  • 1. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation by collagen or epinephrine of platelet responsiveness to aggregation. The possible role of substance(s) released from platelet membranes.
    Yoshida N; Aoki N
    J Lab Clin Med; 1977 Mar; 89(3):603-14. PubMed ID: 839118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
    Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet aggregation in psoriasis.
    Hayashi S; Shimizu I; Miyauchi H; Watanabe S
    Acta Derm Venereol; 1985; 65(3):258-62. PubMed ID: 2411087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
    Salzman EW; Lindon JN; Rodvien R
    J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.